Page 101 - Contract Development News Today

Share this article Share this article ResearchAndMarkets.coms offering. This expert trend report is a comprehensive look at the contract manufacturing landscape surrounding COVID-19 Vaccine in 2020, including analysis of pipeline drugs, clinical trials, CMO activity, Contract Manufacturing Service Agreements, and funding for manufacturing of COVID-19 Vaccines. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that wi...

Share this article Share this article ResearchAndMarkets.coms offering. The Global Pharmaceutical Contract Development & Manufacturing Market is estimated to be USD 100 Bn in 2020 and is expected to reach USD 142.2 Bn by 2025 growing at a CAGR of 7.3%. One of the reasons for the increase in the pharmaceutical contract development and manufacturing industry is the growth of developing biotech. Most of the companies are continuously involved in the development of complex drug compounds to address...

Press release content from NewMediaWire. The AP news staff was not involved in its creation. American BriVision Issues Shareholder Letter Outlining Achievements of 2020 and Outlook for 2021 American BriVision Holding CorporationJanuary 6, 2021 GMT Fremont, CA - ( NewMediaWire ) - January 06, 2021 - American BriVision (Holding) Corporation (OTCQB: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, central nervous system (CNS), and ophthalmo...

(2) Moderna, Inc. (NASDAQ:MRNA), biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Recipharm (STO: RECI-B), a leading contract development and manufacturing organization (CDMO), today announced that they have reached an agreement to support formulation and fill-finish a part of the Moderna COVID-19 Vaccine supply outside of the U.S. The activity will be performed in Recipharms drug product manufacturing facility located in France. Subject to regulatory approva...

Collagen Matrix Acquires the GUIDOR® Synthetic Bone Graft & Membrane Business from Sunstar USA - English News provided by Share this article Share this article OAKLAND, N.J., Dec. 29, 2020 /PRNewswire/ -- Collagen Matrix, Inc., a global leader in regenerative, collagen-based, xenograft-derived medical devices, and portfolio company of Linden Capital Partners ("Linden"), announced today the acquisition of Sunstars Degradable Solutions division (the "Company"), including its GUIDOR ® branded ...

Dutch Vaccine developer Intravacc becomes public shareholding company effective January 1,  2021 - The Dutch State will become sole shareholder - Dr. Jan Groen will continue as Chief Executive Officer of Intravacc BILTHOVEN, Netherlands, Dec. 22, 2020 /PRNewswire/ -- Intravacc, one of the worlds leading translational research and development vaccine organisations, with an extensive track record in developing infectious diseases vaccines, today announced that it will b...

Share this article Share this article BILTHOVEN, Netherlands, Dec. 22, 2020 /PRNewswire/ -- Intravacc, one of the worlds leading translational research and development vaccine organisations, with an extensive track record in developing infectious diseases vaccines, today announced that it will become a Public Shareholding Company with limited liability (B.V.) as of January 1 st, 2021. The Dutch State will be sole shareholder. Until now Intravacc has been separate entity under the responsibili...

(1) Technavio has been monitoring the contract development and manufacturing organization (CDMO) outsourcing market and it is poised to grow by USD 44.17 bn during 2020-2024, progressing at a CAGR of over 9% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/2020122100565...

Shares of pharmaceutical companies were in focus on Monday with Nifty Pharma index hitting a fresh record high of 12,836 on the National Stock Exchange (NSE) in an otherwise subdued market. Cipla, Cadila Healthcare, Lupin, Sun Pharmaceutical Industries and Aurobindo Pharma from the Nifty Pharma index were up in the range of 1 per cent to 2 per cent on the NSE. Meanwhile, Marksans Pharma, Suven Pharma, Novartis, Indoco Remedies, Glenmark Pharmaceuticals, Dr. Lal PathLabs, RPG Life Sciences, S...

This press release was orginally distributed by ReleaseWire Philadelphia, PA -- (ReleaseWire) -- 12/10/2020 -- Frontida BioPharm, Inc., a pharmaceutical Contract Development and Manufacturing Organization based in Philadelphia and Chicago areas, has been granted full certifiable recognition by The Eastern Minority Supplier Development Council as a Minority-Owned Business Enterprise (certified MBE). The Eastern Minority Supplier Development Council (EMSDC) is a 501(c)(3) non-profit organization...